The expansion of Labcorp's oncology portfolio with innovative solutions like Labcorp Plasma Detect and the enhancement of Labcorp Plasma Complete, along with investments in cell and gene therapy, directly impacts the company's positioning in the oncology therapy development market. This strategic move could attract more partnerships and projects, potentially leading to increased revenue and market share in the precision oncology sector.